Literature DB >> 21985118

Risk perceptions, worry, and attitudes about genetic testing for breast cancer susceptibility.

Linda D Cameron1, Jeanne Reeve.   

Abstract

This study assessed the unique associations of risk perceptions and worry with attitudes about genetic testing for breast cancer susceptibility. Women (general practitioner clinic attenders, university students, and first-degree relatives of breast cancer survivors; N = 303) read information about genetic testing and completed measures assessing perceived cancer risk, cancer worry, and genetic testing attitudes and beliefs. Worry was associated with greater interest in genetic testing, stronger beliefs that testing has detrimental emotional consequences, and positive beliefs about benefits of testing and risk-reducing surgeries. Perceived risk was unrelated to interest and associated with more skeptical beliefs about emotional consequences and benefits of testing and risk-reducing surgeries. At low worry levels, testing interest increased with more positive beliefs about testing benefits; at high worry levels, interest was high regardless of benefits beliefs. The findings support Leventhal's Common-Sense Model of self-regulation delineating interactive influences of risk-related cognitions and emotions on information processing and behavior.

Entities:  

Year:  2006        PMID: 21985118     DOI: 10.1080/14768320500230318

Source DB:  PubMed          Journal:  Psychol Health        ISSN: 0887-0446


  38 in total

1.  Dispositional optimism and perceived risk interact to predict intentions to learn genome sequencing results.

Authors:  Jennifer M Taber; William M P Klein; Rebecca A Ferrer; Katie L Lewis; Leslie G Biesecker; Barbara B Biesecker
Journal:  Health Psychol       Date:  2014-10-13       Impact factor: 4.267

2.  Illness perceptions, risk perception and worry in SDH mutation carriers.

Authors:  L T van Hulsteijn; A A Kaptein; A Louisse; N R Biermasz; J W A Smit; E P M Corssmit
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

3.  Identification of cognitive profiles among women considering BRCA1/2 testing through the utilisation of cluster analytic techniques.

Authors:  Pagona Roussi; Kerry A Sherman; Suzanne M Miller; Karen Hurley; Mary B Daly; Andrew Godwin; Joanne S Buzaglo; Kuang-Yi Wen
Journal:  Psychol Health       Date:  2011-07-14

4.  Communication strategies for enhancing understanding of the behavioral implications of genetic and biomarker tests for disease risk: the role of coherence.

Authors:  Linda D Cameron; Theresa M Marteau; Paul M Brown; William M P Klein; Kerry A Sherman
Journal:  J Behav Med       Date:  2011-06-23

Review 5.  Ethical issues of predictive genetic testing for diabetes.

Authors:  Susanne B Haga
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

6.  An affective booster moderates the effect of gain- and loss-framed messages on behavioral intentions for colorectal cancer screening.

Authors:  Rebecca A Ferrer; William M P Klein; Laura E Zajac; Stephanie R Land; Bruce S Ling
Journal:  J Behav Med       Date:  2011-08-18

7.  Considerations for the impact of personal genome information: a study of genomic profiling among genetics and genomics professionals.

Authors:  Julianne M O'Daniel; Susanne B Haga; Huntington F Willard
Journal:  J Genet Couns       Date:  2010-03-30       Impact factor: 2.537

8.  Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk.

Authors:  A E Anderson; K G Flores; W Boonyasiriwat; A Gammon; W Kohlmann; W C Birmingham; M D Schwartz; J Samadder; K Boucher; A Y Kinney
Journal:  Public Health Genomics       Date:  2014-01-14       Impact factor: 2.000

9.  Cancer genetics service interest in women with a limited family history of breast cancer.

Authors:  Tamara J Somers; Julie C Michael; William M P Klein; Andrew Baum
Journal:  J Genet Couns       Date:  2009-05-14       Impact factor: 2.537

10.  Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol.

Authors:  Eleanor Mann; A Toby Prevost; Simon Griffin; Ian Kellar; Stephen Sutton; Michael Parker; Simon Sanderson; Ann Louise Kinmonth; Theresa M Marteau
Journal:  BMC Public Health       Date:  2009-02-20       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.